Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

Posters by Session

Select Session

Thumbnail for Fludarabine/Melphalan Versus Fludarabine/Busulfan Conditioning in AML Undergoing Allogeneic HCT

AML - 1080

Fludarabine/Melphalan Versus Fludarabine/Busulfan Conditioning in AML Undergoing Allogeneic HCT

Aakriti Adhikari

Poster Presenter: Aakriti Adhikari

Thumbnail for Validation of an FLT3 Activity Signature to Predict FLT3 Inhibitor Response in Acute Myeloid Leukemia

AML - 1085

Validation of an FLT3 Activity Signature to Predict FLT3 Inhibitor Response in Acute Myeloid Leukemia

Andrea Palasciano

Poster Presenter: Andrea Palasciano

Thumbnail for CRHBP Activates NF-?B Signaling Through TNIP1 Inhibition in Leukemic Stem Cells: A Novel CRH-Independent Mechanism of Treatment Resistance

Previous 1...21 22 23 24 25 26 27...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

AML - 109

CRHBP Activates NF-?B Signaling Through TNIP1 Inhibition in Leukemic Stem Cells: A Novel CRH-Independent Mechanism of Treatment Resistance

Ryutaro Taenaka

Poster Presenter: Ryutaro Taenaka

Thumbnail for Early Transfusion Independence as a Real-World Prognostic Marker After Hypomethylating Agent-Venetoclax Therapy in Older Adults With Acute Myeloid Leukemia

AML - 1096

Early Transfusion Independence as a Real-World Prognostic Marker After Hypomethylating Agent-Venetoclax Therapy in Older Adults With Acute Myeloid Leukemia

Fathima Shehnaz Ayoobkhan

Poster Presenter: Fathima Shehnaz Ayoobkhan

Thumbnail for Myeloablative vs Reduced-Intensity Conditioning with Post-Transplant Cyclophosphamide in Haploidentical Hematopoietic Cell Transplantation for AML and MDS: A CIBMTR Registry Analysis

AML - 1104

Myeloablative vs Reduced-Intensity Conditioning with Post-Transplant Cyclophosphamide in Haploidentical Hematopoietic Cell Transplantation for AML and MDS: A CIBMTR Registry Analysis

Mohammad Ebad Ur Rehman

Poster Presenter: Mohammad Ebad Ur Rehman

Thumbnail for Racial and Ethnic Differences in Disease Characteristics, Treatment Patterns, and Outcomes in Acute Myeloid Leukemia: A Real-World Single-Center Analysis

AML - 1110

Racial and Ethnic Differences in Disease Characteristics, Treatment Patterns, and Outcomes in Acute Myeloid Leukemia: A Real-World Single-Center Analysis

Harrison Turner

Poster Presenter: Harrison Turner

Thumbnail for Treatment Intensity Rather Than Isoform Is Associated With Improved Outcomes in IDH Mutated AML: A Single-Center Cohort Study

AML - 1113

Treatment Intensity Rather Than Isoform Is Associated With Improved Outcomes in IDH Mutated AML: A Single-Center Cohort Study

Ashlyn O'Leary

Poster Presenter: Ashlyn O'Leary

Thumbnail for Transcriptomic Identification of Ferroptosis-Associated Prognostic Signatures in Acute Myeloid Leukemia

AML - 1130

Transcriptomic Identification of Ferroptosis-Associated Prognostic Signatures in Acute Myeloid Leukemia

Punitha Muruganantham

Poster Presenter: Punitha Muruganantham

Thumbnail for Acquired Factor XIII Deficiency in Myeloid Malignancies: An Underrecognized Cause of Severe Hemorrhagic Complications

AML - 1150

Acquired Factor XIII Deficiency in Myeloid Malignancies: An Underrecognized Cause of Severe Hemorrhagic Complications

Alfadil Haroon

Poster Presenter: Alfadil Haroon

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors